Literature DB >> 24494163

The Effect of Concomitant Ethanol and Opium Consumption on Lipid Profiles and Atherosclerosis in Golden Syrian Hamster's Aorta.

Jahanbanoo Shahryari1, Moein Poormorteza2, Arash Noori-Sorkhani2, Kouros Divsalar3, Ebrahim Abbasi-Oshaghi4.   

Abstract

BACKGROUND: Cardiovascular disease (CVD) is the main cause of mortality in the world and is normally argued as the third cause of all mortalities. Opium and alcohol every day consumption can cause people to have many health problems. The present study aimed to assess the effect of ethanol and opium consumption on lipid profiles and atherosclerosis in aorta.
METHODS: Twenty four male golden Syrian hamsters were randomly divided into four treatment groups (n = 6): Control, addicted (40 mg/kg), alcohol (6.0 g/kg) and combination of opium and alcohol. All of the hamsters were scarified and their livers were removed immediately and fixed in formalin solution 10%. The plasma levels of the lipid profiles were measured enzymatically. Aorta sections were examined by a pathologist.
FINDINGS: The amount of the total cholesterol significantly increased in ethanol (P < 0.05) and combination (P < 0.05) groups, while it had a non-significant decrease in opium group. Serum triglyceride significantly increased in ethanol (P < 0.05) and combination (P < 0.001) groups, as well as this parameter increased in opium group but it was not significant. Low-density lipoprotein cholesterol (LDL-C) markedly increased in the combination group (P < 0.05). No significant difference was observed in serum LDL-C among other treatment groups. Levels of high-density lipoprotein cholesterol had a significant rise only in ethanol group. Change in aorta histology was not significant.
CONCLUSION: The results showed that consumption of opium plus alcohol has harmful effects on lipid profile; however, it had no effect on aorta histology that was maybe due to the short period of the treatment.

Entities:  

Keywords:  Aorta; Atherosclerosis; Cholesterol; Ethanol; Opium

Year:  2013        PMID: 24494163      PMCID: PMC3905481     

Source DB:  PubMed          Journal:  Addict Health        ISSN: 2008-4633


Introduction

Reviewing the history of using opium indicates that it goes back to the earliest times of recorded history. Almost 3000 years BC, the Sumerians were the first people who used opium for religious purposes.1 Opium has been known and used as an analgesic since ancient times. This substance is extracted from poppy plant called Papaver Somniferum. Opium contains eighty different alkaloid compounds the most important of which is morphine.2,3 Besides, alcoholic drinks which are contained different percentages of ethanol are used orally.4 Ethanol has always been considered as one of the most well-known risk factors for various diseases.5 Fortunately, in Iran alcohol consumption is much less common due to religious, cultural and society beliefs. Alcohol is quickly absorbed by liver after oral or intravenous consumption; moreover, some of it would be unchanged excreted through urine, sweat and breath.5-7 Approximately 90% of alcohol in liver is metabolized to estolide and then to acetate. Ethanol is commonly the cause of the primary etiologic factor or one among many factors associated with esophageal dysfunction.6 Indiscriminate use of alcohol may break down the gastric mucosal barrier as well as causing acute and chronic gastritis.5 It may cause chronic diarrhea and malabsorption in the small intestine.5 Ethanol alters fat and cirrhotic hepatitis in the liver. Alcohol is a primary oppressive for the central nervous system (CNS) which has negative effects on the cardiovascular system and consequently causes heart failure such as arrhythmia, cardiomyopathy, hemorrhagic stroke, and increased systolic and diastolic blood pressure. In addition, it can decrease skeletal muscle strength and irreversible damages and also can cause feeling warm and increase sweating. Ethanol also inhibits the vasopressin release from the posterior pituitary and may cause increased dieresis. Furthermore, alcohol can cause gradual loss of proteins, vitamins and minerals, and body might be susceptible to complications due to nutritional deficiencies.7-10 It might negatively impact on fetus, endocrine, and immune system.8,9,11 The present study aimed to identify the effect of concomitant ethanol and opium consumption on lipid profiles and atherosclerosis in golden Syrian hamster’s aorta.

Methods

Animal Preparation First, 24 male Syrian golden hamsters were prepared by the Animal’s House of School of Medicine. They were randomly divided into four groups each contained six hamsters. Each hamster was marked by a special number. The animals were kept under the following conditions: Temperature 20°C ± 1, humidity 50% to 55%, 12 hours light (set by a timer), 12 hours darkness (set by a timer). All of them were kept with the above conditions for a month and their cage and place was cleaned twice a week. Study Population Syrian golden hamsters were divided into the following groups (6 in each group): 1. Control (including 6 hamsters received their normal diet, and were not alcoholic and addicts), 2. Addicted (including 6 hamsters received opium), 3. Alcoholic (6 hamsters received alcohol), 4. Combined alcohol and drug (including 6 hamsters that received simultaneous opium and alcohol). Method of Opium Addicting In order to develop oral addiction, hamsters were gavaged with oral opium for four 48-hours periods within two days. Thus, 10 mg at the first 48 hours, 20 mg at the second 48 hours, 30 mg at the third 48 hours, and finally 40 mg of opium were solved in hot water at the end of the day 30 and then after cooling it was gavaged to the hamsters 0.5 ml in 7 a.m. and 0.5 ml in 7 p.m.12 After the forth night, in order to make sure they are addicted, 4 mg/kg naloxone injection intravenously was injected to the head of two randomly selected animals and morphine withdrawal symptoms were examined.13,14 Method of Alcohol Addicting In the ethanol group, 6 g/kg ethanol was gavaged.15 Thus, 0.3 g ethanol in 7 a.m. and 0.3 g in 7 p.m. was gavaged to the hamsters. Sampling Method First, the hamsters were anesthetized through intraperitoneal injecting with sodium thiopental (50 mg/kg) and then were placed in side. Their head was pulled back using tip of the thumb and forefinger and then the needle of blood sampling tool was entered into the orbital sinus.16 Three milliliters of blood was taken and the samples were placed in numbered tubes and then were centrifuged in 30 minutes and their serum was eliminated; the serum was kept in -20°C until sending the samples to the laboratory. The serums were sent to the Razi Laboratory of Kerman and their lipid profiles were measured. Assessment of Aortic Samples For aorta separations, first animals were anesthetized through intraperitoneal injecting with sodium thiopental (50 mg/kg) and then were sacrificed through cutting the neck vessels. Then, they were placed in supine position and their chest was opened using mead substernal incision and their heart was extracted with their aorta. Thereafter, the aortic arch was removed and fixed in 10% formalin solution for at least 24 hours. In the next step, the paraffin blocks were prepared from the animal aorta and were converted to rotary microtome to 5 micrometer sections. The cutoffs were stained with hematoxylin eosin. For assessing the macrophage marker, marker CD68 was used to evaluate the staining using heat induce Epitop retrival (HIER). For IHC through HIER, first 7-micron tissue sections were transferred to pre-prepared Poly-L-lysine slides. Then, after the removal of paraffin and hydration with alcohol, rinse was done by neutralizing the endogenous peroxidase by hydrogen peroxide. Epitope retrieval was then conducted by a microwave and antibody CD68 was carefully added after the washing steps. Incubation was performed after rewashing and detection of antibodies was performed by adding envision reagent and 3, 3' diaminobenzidine (DBA). Thereafter, the slides were washed and staining the slide’s background was performed by hematoxylin and they were ready to be reviewed microscopically. Histological slides were examined by light microscope by a blinded pathologist in terms of presence or absence of fatty streak, fibrous plaque formation and calcification of the media and changes intensity were surveyed and then grading was performed as below:17 Grade 1: absence, Grade 2: mild, Grade 3: moderate, and Grade 4: intense Data Analysis for Study Objectives The results gained by the effect of opium on aortic pathology of opium and ethanol addicted, and normal hamsters was done using the SPSS for Windows 15.0 (SPSS Inc., Chicago, IL, USA) and Kruskal-Wallis test, and while P < 0.05, the differences were statistically significant. SPSS and analysis of variance (ANOVA) were used for analyzing tests such as total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C), and while P < 0.05, the differences were statistically significant.

Results

Table 1 illustrates the mean and SD of lipid parameters in the four studied groups. In opium group, the triglyceride (TG) and LDL-C level increased compared to the control group (P < 0.05). In this group, HDL level decreased (P < 0.05). In ethanol group, the cholesterol, TG and HDL level increased compared to the control group (P < 0.05). In the opium-ethanol group, cholesterol, TG and LDL-C level increased compared to the control group (P < 0.05). In the opium-ethanol group, cholesterol, TG, HDL-C and LDL-C level increased compared to the opium group (P < 0.05). In the opium-ethanol group, TG, HDL-C and LDL-C level increased compared to the ethanol group (P < 0.05).
Table 1

The level of lipid parameters in the groups

GroupsCholesterol (mg/dl)TG (mg/dl)HDL-C (mg/dl)LDL-C (mg/dl)
Control78.2 ± 5.188.4 ± 4.434.4 ± 3.427.2 ± 4.2
Opium71.1 ± 4.6101.2 ± 7.124.1 ± 2.055.7 ± 4.7
Ethanol128.4 ± 7.0187.2 ± 6.371.8 ± 5.522.7 ± 2.3
Opium-Ethanol135.4 ± 6.2230.2 ± 9.239.5 ± 3.2121.6 ± 6.5

The numbers are as mean ± SD (6 hamsters in each group); TG: Triglycerides

HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol

Histological Findings No change was observed in the opium group compared to the control group. No change was observed in ethanol group compared to the control group. Besides, no change was observed in the opium-ethanol group compared to the control group (Figures 1-4).
Figure 1

Aortic sections of the control group stained with hematoxylin eosin and heat induce epitope retrieval No certain changes were observed in the test groups compared to the control group

Figure 2

Aortic sections of the ethanol group stained with hematoxylin eosin and heat induce pitope retrieval No certain changes were observed in the test groups compared to the control group

Figure 3

Aortic sections of the opium group stained with hematoxylin eosin staining and heat induce epitope retrieval No certain changes were observed in the test groups compared to the control group

Figure 4

Aortic sections of the opium-ethanol group stained with hematoxylin eosin staining and heat induce epitope retrieval No certain changes were observed in the test groups compared to the control group

Discussion

In the present study, the level of TG and LDL increased and HDL decreased in the opium group compared to the control group. The study of Mohammadi et al. showed that opium decreased cholesterol, LDL and HDL.12 In addition, the study of Najafipour et al. showed that cholesterol, LDL and TG were unchanged in addicted groups than non-addicted groups; however, the HDL level decreased in the addicted groups than non-addicted groups.18 Furthermore, Kouros et al. suggested that the serum cholesterol level was decreased in the addicted groups than non-addicted groups while TG level of addicted groups than non-addicted groups showed no significant difference.19 The study of Karam et al. also showed that HDL level was lower in addicted diabetes individuals with non-insulin dependency than non-addicted diabetes individuals with non-insulin dependency.2 Since the HDL level is an independent predictor of atherosclerosis,15 it seems that opium dependency can increase the atherosclerosis through decreasing the HDL.12 As shown in the study of Sadeghian et al., the major cause of premature coronary artery disease in males in Iran is due to opium addiction.20 The study of Foody et al. also introduced HDL as a major and independent predictor of survival after the coronary artery bypass graft surgery.21 In the present study, cholesterol, TG and HDL level increased in the ethanol group compared to the control group. In the study of Baraona et al. consumption of ethanol increased the HDL level in rats.22 Moreover, another study showed that alcohol can increase the HDL level.23,24 Gottrand et al. showed that ethanol may increase HDL and is associated with increased concentration of apolipoprotein A-I and A-II.25 Besides, Hojnacki et al. showed that ethanol consumption can increase HDL and concentration of apolipoprotein AI in monkeys.26 Out of the mentioned studies, it can be resulted that alcohol can increase HDL level through increasing the transport of apolipoprotein A-I and A-II. In the present study, given the increase of cholesterol, TG and LDLD level in the ethanol and opium groups than the control group, it can be concluded that concomitant consumption of ethanol and opium has much more harmful effects than the groups that use none of the substances. In this study, none of the treatment groups had any histological changes compared to the control group. The results of the present study were completely in accordance with the study results of Shirpoor et al. In that study, atherosclerotic plaques were observed in hematoxylin eosin staining of the ethanol group, besides, +CD68 active macrophages has been reported using the IHC staining.27 The difference of the present study with Shirpoor’s study was in the animals used and the length of the treatment regimen. Unlike the study results of Shirpoor et al., the study of Thun et al. showed that ethanol consumption has decreased the risk of myocardial infarction (MI).28 Besides, the study of Rehm et al. confirmed the protective effects of ethanol on heart.29
  25 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Alcohol delays clearance of lipoproteins from the circulation.

Authors:  J L Hojnacki; J E Cluette-Brown; M Dawson; R N Deschenes; J J Mulligan
Journal:  Metabolism       Date:  1992-11       Impact factor: 8.694

3.  Alcohol consumption and ethyl carbamate.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  2010

4.  Alcohol and coronary heart disease: the roles of HDL-cholesterol and smoking.

Authors:  M Mänttäri; L Tenkanen; T Alikoski; V Manninen
Journal:  J Intern Med       Date:  1997-02       Impact factor: 8.989

5.  Effects of ethanol on the adrenal medulla of the rat.

Authors:  L A Pohorecky; L S Jaffe; H A Berkeley
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

6.  Effects of acute administration of ethanol on the rat adrenal cortex.

Authors:  Tatjana Milovanović; Mirela Budec; Ljiljana Balint-Perić; Vesna Koko; Vera Todorović
Journal:  J Stud Alcohol       Date:  2003-09

7.  Opium consumption in men and diabetes mellitus in women are the most important risk factors of premature coronary artery disease in Iran.

Authors:  Saeed Sadeghian; Pooyeh Graili; Mojtaba Salarifar; Abbas Ali Karimi; Soodabeh Darvish; Seyed Hesameddin Abbasi
Journal:  Int J Cardiol       Date:  2009-04-05       Impact factor: 4.164

Review 8.  Clinical pathology of alcohol.

Authors:  V Marks
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

9.  Passive opium smoking does not have beneficial effect on plasma lipids and cardiovascular indices in hypercholesterolemic rabbits with ischemic and non-ischemic hearts.

Authors:  Hamid Najafipour; Siyavash Joukar; Reza Malekpour-Afshar; Fateme Mirzaeipour; Hamid Reza Nasri
Journal:  J Ethnopharmacol       Date:  2009-11-13       Impact factor: 4.360

Review 10.  Alcohol-related morbidity and mortality.

Authors:  Jürgen Rehm; Gerhard Gmel; Christopher T Sempos; Maurizio Trevisan
Journal:  Alcohol Res Health       Date:  2003
View more
  6 in total

1.  Investigating Changes in Serum Biochemical Parameters in Opium Addicts Before and During Addiction Treatment.

Authors:  Sedigheh Barzehkar; Mohammad Hossein Gozashti; Kouros Divsalar; Mahdieh Mashrouteh; Amir Hossein Darvishi-Lardi
Journal:  Addict Health       Date:  2016

Review 2.  The Role of Anethum graveolens L. (Dill) in the Management of Diabetes.

Authors:  Mohammad Taghi Goodarzi; Iraj Khodadadi; Heidar Tavilani; Ebrahim Abbasi Oshaghi
Journal:  J Trop Med       Date:  2016-10-18

3.  Effects of Opium Addiction on Some Biochemical Factors in Diabetic Rats.

Authors:  Gholamreza Asadikaram; Sina Vakili; Hamed Akbari; Marjan Kheirmand-Parizi; Erfan Sadeghi; Majid Asiabanha; Nader Shahrokhi
Journal:  Addict Health       Date:  2018-04

4.  The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms.

Authors:  Samaneh Nakhaee; Saeedeh Ghasemi; Kimiya Karimzadeh; Nasim Zamani; Samaneh Alinejad-Mofrad; Omid Mehrpour
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-04-17

5.  Protective effects of cerium oxide nanoparticles in non-alcoholic fatty liver disease (NAFLD) and carbon tetrachloride-induced liver damage in rats: Study on intestine and liver.

Authors:  Ebrahim Abbasi; Seyed Alireza Vafaei; Nima Naseri; Ali Darini; Masoumeh Taheri Azandaryani; Farhad Kian Ara; Fatemeh Mirzaei
Journal:  Metabol Open       Date:  2021-11-18

6.  Favorable effects of Anethum graveolens on liver oxidative stress and cholesterol 7 alpha-hydroxylase levels in non-alcoholic fatty liver disease (NAFLD) rat models.

Authors:  Ebrahim Abbasi; Mohammad Taghi Goodarzi; Heidar Tayebinia; Massoud Saidijam; Iraj Khodadadi
Journal:  Metabol Open       Date:  2021-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.